These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 25180640

  • 1. Walking capacity and ability are more impaired in progressive compared to relapsing type of multiple sclerosis.
    Feys P, Bibby BM, Baert I, Dalgas U.
    Eur J Phys Rehabil Med; 2015 Apr; 51(2):207-10. PubMed ID: 25180640
    [Abstract] [Full Text] [Related]

  • 2. A cross-sectional study on the relationship between cardiorespiratory fitness, disease severity and walking speed in persons with Multiple Sclerosis.
    Madsen LT, Dalgas U, Hvid LG, Bansi J.
    Mult Scler Relat Disord; 2019 Apr; 29():35-40. PubMed ID: 30658262
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the timed 25-foot and the 100-meter walk as performance measures in multiple sclerosis.
    Phan-Ba R, Pace A, Calay P, Grodent P, Douchamps F, Hyde R, Hotermans C, Delvaux V, Hansen I, Moonen G, Belachew S.
    Neurorehabil Neural Repair; 2011 Sep; 25(7):672-9. PubMed ID: 21436388
    [Abstract] [Full Text] [Related]

  • 4. Rapid foot-tapping but not hand-tapping ability is different between relapsing-remitting and progressive multiple sclerosis.
    Sato S, Lim J, Miehm JD, Buonaccorsi J, Rajala C, Khalighinejad F, Ionete C, Kent JA, van Emmerik REA.
    Mult Scler Relat Disord; 2020 Jun; 41():102031. PubMed ID: 32172213
    [Abstract] [Full Text] [Related]

  • 5. Vitamin D is associated with degree of disability in patients with fully ambulatory relapsing-remitting multiple sclerosis.
    Thouvenot E, Orsini M, Daures JP, Camu W.
    Eur J Neurol; 2015 Mar; 22(3):564-9. PubMed ID: 25530281
    [Abstract] [Full Text] [Related]

  • 6. Role of Demographic and Clinical Factors in Cognitive Functioning of Persons with Relapsing-Remitting and Progressive Multiple Sclerosis.
    Costa SL, DeLuca J, Sandroff BM, Goverover Y, Chiaravalloti ND.
    J Int Neuropsychol Soc; 2018 Feb; 24(2):139-146. PubMed ID: 28830576
    [Abstract] [Full Text] [Related]

  • 7. Responder rates to fampridine differ between clinical subgroups of MS patients and patient reported outcome influences treatment decision making.
    van Munster CEP, Kaya L, Lam KH, Kalkers NF, Killestein J, Uitdehaag BMJ.
    Mult Scler Relat Disord; 2020 Feb; 38():101489. PubMed ID: 31731213
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Walking capacities in multiple sclerosis measured by global positioning system odometer.
    Créange A, Serre I, Levasseur M, Audry D, Nineb A, Boërio D, Moreau T, Maison P, Réseau SINDEFI-SEP.
    Mult Scler; 2007 Mar; 13(2):220-3. PubMed ID: 17439888
    [Abstract] [Full Text] [Related]

  • 11. Cognitive impairment in a population-based study of patients with multiple sclerosis: differences between late relapsing-remitting, secondary progressive and primary progressive multiple sclerosis.
    Planche V, Gibelin M, Cregut D, Pereira B, Clavelou P.
    Eur J Neurol; 2016 Feb; 23(2):282-9. PubMed ID: 25903918
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cognitive impairment differs between primary progressive and relapsing-remitting MS.
    Ruet A, Deloire M, Charré-Morin J, Hamel D, Brochet B.
    Neurology; 2013 Apr 16; 80(16):1501-8. PubMed ID: 23516324
    [Abstract] [Full Text] [Related]

  • 14. Relapses and progression of disability in multiple sclerosis.
    Confavreux C, Vukusic S, Moreau T, Adeleine P.
    N Engl J Med; 2000 Nov 16; 343(20):1430-8. PubMed ID: 11078767
    [Abstract] [Full Text] [Related]

  • 15. Walking speed, rather than Expanded Disability Status Scale, relates to long-term patient-reported impact in progressive MS.
    Bosma L, Kragt JJ, Polman CH, Uitdehaag BM.
    Mult Scler; 2013 Mar 16; 19(3):326-33. PubMed ID: 22907939
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls.
    Goldman MD, Marrie RA, Cohen JA.
    Mult Scler; 2008 Apr 16; 14(3):383-90. PubMed ID: 17942508
    [Abstract] [Full Text] [Related]

  • 19. Natural history of multiple sclerosis: a unifying concept.
    Confavreux C, Vukusic S.
    Brain; 2006 Mar 16; 129(Pt 3):606-16. PubMed ID: 16415308
    [Abstract] [Full Text] [Related]

  • 20. Utility of the Six-Spot Step Test as a Measure of Walking Performance in Ambulatory Individuals With Multiple Sclerosis.
    Fritz NE, Jiang A, Keller J, Zackowski KM.
    Arch Phys Med Rehabil; 2016 Apr 16; 97(4):507-512. PubMed ID: 26577146
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.